{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T13:31:39Z","timestamp":1792503099555,"version":"4.5.0"},"reference-count":38,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Psychiatry"],"published-print":{"date-parts":[[2021,6,1]]},"DOI":"10.1001\/jamapsychiatry.2021.0005","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T11:32:56Z","timestamp":1615375976000},"page":"623","source":"Crossref","is-referenced-by-count":172,"title":["Association of Antihypertensive Drug Target Genes With Psychiatric Disorders"],"prefix":"10.1001","volume":"78","author":[{"given":"Solal","family":"Chauquet","sequence":"first","affiliation":[{"name":"Institute for Molecular Biosciences, University of Queensland, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Institute for Molecular Biosciences, University of Queensland, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C.","family":"O\u2019Donovan","sequence":"additional","affiliation":[{"name":"MRC (Medical Research Council) Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James T. R.","family":"Walters","sequence":"additional","affiliation":[{"name":"MRC (Medical Research Council) Centre for Neuropsychiatric Genetics and Genomics, Division of Psychological Medicine and Clinical Neurosciences, School of Medicine, Cardiff University, Cardiff, United Kingdom"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi R.","family":"Wray","sequence":"additional","affiliation":[{"name":"Institute for Molecular Biosciences, University of Queensland, Brisbane, Australia"},{"name":"Queensland Brain Institute, University of Queensland, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Shah","sequence":"additional","affiliation":[{"name":"Institute for Molecular Biosciences, University of Queensland, Brisbane, Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"key":"yoi210001r1","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.jad.2017.09.002","article-title":"Hypertension risk and clinical care in patients with bipolar disorder or schizophrenia: a systematic review and meta-analysis.","volume":"225","author":"Ayerbe","year":"2018","journal-title":"J Affect Disord"},{"issue":"9","key":"yoi210001r2","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/ng.209","article-title":"Collaborative genome-wide association analysis supports a role for ANK3 and CACNA1C in bipolar disorder.","volume":"40","author":"Ferreira","year":"2008","journal-title":"Nat Genet"},{"issue":"10","key":"yoi210001r3","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1038\/mp.2016.86","article-title":"A systematic review of calcium channel antagonists in bipolar disorder and some considerations for their future development.","volume":"21","author":"Cipriani","year":"2016","journal-title":"Mol Psychiatry"},{"issue":"1","key":"yoi210001r4","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1080\/17425255.2019.1558206","article-title":"Applications of calcium channel blockers in psychiatry: pharmacokinetic and pharmacodynamic aspects of treatment of bipolar disorder.","volume":"15","author":"Dubovsky","year":"2019","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"5","key":"yoi210001r5","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1161\/HYPERTENSIONAHA.116.08188","article-title":"Monotherapy with major antihypertensive drug classes and risk of hospital admissions for mood disorders.","volume":"68","author":"Boal","year":"2016","journal-title":"Hypertension"},{"issue":"4","key":"yoi210001r6","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1001\/jamapsychiatry.2018.3907","article-title":"Association of hydroxylmethyl glutaryl coenzyme A reductase inhibitors, L-type calcium channel antagonists, and biguanides with rates of psychiatric hospitalization and self-harm in individuals with serious mental illness.","volume":"76","author":"Hayes","year":"2019","journal-title":"JAMA Psychiatry"},{"key":"yoi210001r7","doi-asserted-by":"publisher","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading mendelian randomisation studies: a guide, glossary, and checklist for clinicians.","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"issue":"1","key":"yoi210001r8","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.1038\/s41467-020-15421-7","article-title":"Genome-wide association study identifies 143 loci associated with 25 hydroxyvitamin D concentration.","volume":"11","author":"Revez","year":"2020","journal-title":"Nat Commun"},{"issue":"5","key":"yoi210001r9","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1093\/ije\/dyz176","article-title":"Assessing causal links between metabolic traits, inflammation and schizophrenia: a univariable and multivariable, bidirectional Mendelian-randomization study.","volume":"48","author":"Lin","year":"2019","journal-title":"Int J Epidemiol"},{"issue":"Database issue","key":"yoi210001r10","doi-asserted-by":"publisher","first-page":"D668","DOI":"10.1093\/nar\/gkj067","article-title":"DrugBank: a comprehensive resource for in silico drug discovery and exploration.","volume":"34","author":"Wishart","year":"2006","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"yoi210001r11","doi-asserted-by":"publisher","first-page":"D945","DOI":"10.1093\/nar\/gkw1074","article-title":"The ChEMBL database in 2017.","volume":"45","author":"Gaulton","year":"2017","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"yoi210001r13","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/s41588-018-0059-2","article-title":"Common schizophrenia alleles are enriched in mutation-intolerant genes and in regions under strong background selection.","volume":"50","author":"Pardi\u00f1as","year":"2018","journal-title":"Nat Genet"},{"issue":"5","key":"yoi210001r14","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/s41588-019-0397-8","article-title":"Genome-wide association study identifies 30 loci associated with bipolar disorder.","volume":"51","author":"Stahl","year":"2019","journal-title":"Nat Genet"},{"issue":"3","key":"yoi210001r15","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1038\/s41593-018-0326-7","article-title":"Genome-wide meta-analysis of depression identifies 102 independent variants and highlights the importance of the prefrontal brain regions.","volume":"22","author":"Howard","year":"2019","journal-title":"Nat Neurosci"},{"issue":"5","key":"yoi210001r16","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/ng.3538","article-title":"Integration of summary data from GWAS and eQTL studies predicts complex trait gene targets.","volume":"48","author":"Zhu","year":"2016","journal-title":"Nat Genet"},{"issue":"10","key":"yoi210001r17","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/s41588-018-0205-x","article-title":"Genetic analysis of over 1 million people identifies 535 new loci associated with blood pressure traits.","volume":"50","author":"Evangelou","year":"2018","journal-title":"Nat Genet"},{"issue":"1","key":"yoi210001r18","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1038\/s41467-017-02317-2","article-title":"Causal associations between risk factors and common diseases inferred from GWAS summary data.","volume":"9","author":"Zhu","year":"2018","journal-title":"Nat Commun"},{"issue":"6","key":"yoi210001r19","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1038\/tpj.2009.70","article-title":"A genome-wide association study identifies new loci for ACE activity: potential implications for response to ACE inhibitor.","volume":"10","author":"Chung","year":"2010","journal-title":"Pharmacogenomics J"},{"issue":"9","key":"yoi210001r20","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.439","article-title":"The intracellular angiotensin system buffers deleterious effects of the extracellular paracrine system.","volume":"8","author":"Villar-Cheda","year":"2017","journal-title":"Cell Death Dis"},{"issue":"4","key":"yoi210001r21","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1161\/01.HYP.31.4.912","article-title":"N-domain-specific substrate and C-domain inhibitors of angiotensin-converting enzyme: angiotensin-(1-7) and keto-ACE.","volume":"31","author":"Deddish","year":"1998","journal-title":"Hypertension"},{"issue":"5","key":"yoi210001r22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1038\/nrneph.2018.15","article-title":"Angiotensin-converting enzyme in innate and adaptive immunity.","volume":"14","author":"Bernstein","year":"2018","journal-title":"Nat Rev Nephrol"},{"issue":"3","key":"yoi210001r23","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/S2215-0366(14)00122-9","article-title":"Inflammation and immunity in schizophrenia: implications for pathophysiology and treatment.","volume":"2","author":"Khandaker","year":"2015","journal-title":"Lancet Psychiatry"},{"issue":"3","key":"yoi210001r24","first-page":"369","article-title":"Association between insertion\/deletion polymorphism in angiotension converting enzyme and susceptibility to schizophrenia.","volume":"44","author":"Mazaheri","year":"2015","journal-title":"Iran J Public Health"},{"issue":"2","key":"yoi210001r25","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1177\/1470320313495909","article-title":"The insertion\/deletion polymorphism in the angiotensin-converting enzyme and susceptibility to schizophrenia or Parkinson\u2019s disease: a meta-analysis.","volume":"16","author":"Song","year":"2015","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"yoi210001r26","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.schres.2018.06.023","article-title":"Lower circulating levels of angiotensin-converting enzyme (ACE) in patients with schizophrenia.","volume":"202","author":"Mohite","year":"2018","journal-title":"Schizophr Res"},{"key":"yoi210001r27","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2015.181","article-title":"Convergent evidences from human and animal studies implicate angiotensin I-converting enzyme activity in cognitive performance in schizophrenia.","volume":"5","author":"Gadelha","year":"2015","journal-title":"Transl Psychiatry"},{"issue":"8","key":"yoi210001r29","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1038\/ng.3314","article-title":"The support of human genetic evidence for approved drug indications.","volume":"47","author":"Nelson","year":"2015","journal-title":"Nat Genet"},{"issue":"12","key":"yoi210001r30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008489","article-title":"Are drug targets with genetic support twice as likely to be approved? Revised estimates of the impact of genetic support for drug mechanisms on the probability of drug approval.","volume":"15","author":"King","year":"2019","journal-title":"PLoS Genet"},{"issue":"7809","key":"yoi210001r31","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41586-020-2267-z","article-title":"Evaluating drug targets through human loss-of-function genetic variation.","volume":"581","author":"Minikel","year":"2020","journal-title":"Nature"},{"issue":"1","key":"yoi210001r32","doi-asserted-by":"publisher","first-page":"2282","DOI":"10.1038\/s41467-018-04558-1","article-title":"Identifying gene targets for brain-related traits using transcriptomic and methylomic data from blood.","volume":"9","author":"Qi","year":"2018","journal-title":"Nat Commun"},{"issue":"1","key":"yoi210001r33","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/schbul\/14.1.39","article-title":"Late-onset schizophrenia: an overview.","volume":"14","author":"Harris","year":"1988","journal-title":"Schizophr Bull"},{"issue":"4","key":"yoi210001r34","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1111\/jch.12063","article-title":"Visual hallucinations related to angiotensin-converting enzyme inhibitor use: case reports and review.","volume":"15","author":"Doane","year":"2013","journal-title":"J Clin Hypertens (Greenwich)"},{"issue":"2","key":"yoi210001r35","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1176\/ajp.142.2.270a","article-title":"Reversal of captopril-induced psychosis with naloxone.","volume":"142","author":"Gillman","year":"1985","journal-title":"Am J Psychiatry"},{"issue":"5","key":"yoi210001r36","first-page":"558","article-title":"Enalapril-induced acute psychosis.","volume":"25","author":"Ahmad","year":"1991","journal-title":"Ann Pharmacother"},{"issue":"6","key":"yoi210001r37","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1159\/000177156","article-title":"Losartan and reversible psychosis.","volume":"87","author":"Ahmad","year":"1996","journal-title":"Cardiology"},{"issue":"11","key":"yoi210001r38","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1111\/jgs.2000.48.11.1533","article-title":"Quinapril-associated acute psychosis in an older woman.","volume":"48","author":"Tarlow","year":"2000","journal-title":"J Am Geriatr Soc"},{"key":"yoi210001r12","doi-asserted-by":"crossref","unstructured":"V\u00f5sa? U, Claringbould? A, Westra? H-J, . Unraveling the polygenic architecture of complex traits using blood eQTL meta-analysis. Posted online October 19, 2018. bioRxiv. doi:10.1101\/447367","DOI":"10.1101\/447367"},{"key":"yoi210001r28","doi-asserted-by":"crossref","unstructured":"Schizophrenia Working Group of the Psychiatric Genomics Consortium. Mapping genomic loci prioritises genes and implicates synaptic biology in schizophrenia. Posted September 13, 2020. medRxiv. doi:10.1101\/2020.09.12.20192922","DOI":"10.1101\/2020.09.12.20192922"}],"container-title":["JAMA Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/articlepdf\/2777005\/jamapsychiatry_chauquet_2021_oi_210001_1622231742.29897.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,2]],"date-time":"2021-06-02T12:20:45Z","timestamp":1622636445000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapsychiatry\/fullarticle\/2777005"}},"subtitle":["A Mendelian Randomization Study"],"short-title":[],"issued":{"date-parts":[[2021,6,1]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.0005","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.03.19.20039412","asserted-by":"object"}]},"ISSN":["2168-622X"],"issn-type":[{"value":"2168-622X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6,1]]}}}